| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744910 | Clinical Microbiology and Infection | 2018 | 23 Pages |
Abstract
Adding tigecycline to CDI standard therapy did not increase the clinical cure nor reduce the rate of CDI recurrences.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N. Benea, J. RodrÃguez-Baño, A. Hristea,